다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Advanced drug delivery reviews, v.61 no.9, 2009년, pp.746 - 759
Rao, Donald D. (Gradalis, Inc., Dallas, TX, USA) , Vorhies, John S. (Gradalis, Inc., Dallas, TX, USA) , Senzer, Neil (Gradalis, Inc., Dallas, TX, USA) , Nemunaitis, John (Gradalis, Inc., Dallas, TX, USA)
AI-Helper
AbstractRNA interference (RNAi) is a natural process through which expression of a targeted gene can be knocked down with high specificity and selectivity. Using available technology and bioinformatics investigators will soon be able to identify relevant bio molecular tumor network hubs as potential...
Curr. Treatm. Opt. Oncol. Kaklamani 7 123 2006 10.1007/s11864-006-0047-0 Gene expression in breast cancer
Evid. Rep./Technol. Assess. (Full Rep.) Marchionni 1 2007 Impact of gene expression profiling tests on breast cancer outcomes
Int. J. Cancer. Habermann 124 7 1552 2009 10.1002/ijc.24017 The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome
Breast Cancer Res. Wirapati 10 R65 2008 10.1186/bcr2124 Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Proc. Natl. Acad. Sci. U. S. A. Sorlie 100 8418 2003 10.1073/pnas.0932692100 Repeated observation of breast tumor subtypes in independent gene expression data sets
Expert Opin. Pharmacother. Davies 7 2243 2006 10.1517/14656566.7.16.2243 Point mutations of protein kinases and individualised cancer therapy
Nat. Rev., Cancer Letai 8 121 2008 10.1038/nrc2297 Diagnosing and exploiting cancer's addiction to blocks in apoptosis
Clin. Cancer Res. Olopade 14 7988 2008 10.1158/1078-0432.CCR-08-1211 Advances in breast cancer: pathways to personalized medicine
Cancer Gene Ther. Nemunaitis 14 686 2007 10.1038/sj.cgt.7701057 Proof concept for clinical justification of network mapping for personalized cancer therapeutics
Cancer Res. Stein 48 2659 1988 Oligodeoxynucleotides as inhibitors of gene expression: a review
J. Biochem. Biophys. Methods Zamaratski 48 189 2001 10.1016/S0165-022X(01)00149-X A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H
Biochim. Biophys. Acta Crooke 1489 31 1999 10.1016/S0167-4781(99)00148-7 Molecular mechanisms of action of antisense drugs
Methods Enzymol. Castanotto 313 401 2000 10.1016/S0076-6879(00)13025-3 Intracellular expression and function of antisense catalytic RNAs
Science Rossi 285 1685 1999 10.1126/science.285.5434.1685 Ribozymes in the nucleolus
Proc. Natl. Acad. Sci. U. S. A. Santoro 94 4262 1997 10.1073/pnas.94.9.4262 A general purpose RNA-cleaving DNA enzyme
Hum. Gene Ther. Wu 10 2847 1999 10.1089/10430349950016573 Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes)
Am. J. Transplant. Ichim 4 1227 2004 10.1111/j.1600-6143.2004.00530.x RNA interference: a potent tool for gene-specific therapeutics
Nature Elbashir 411 494 2001 10.1038/35078107 Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Science Liu 305 1437 2004 10.1126/science.1102513 Argonaute2 is the catalytic engine of mammalian RNAi
Trends Biotechnol. Paroo 22 390 2004 10.1016/j.tibtech.2004.06.004 Challenges for RNAi in vivo
Clin. Exp. Pharmacol. Physiol. Aoki 30 96 2003 10.1046/j.1440-1681.2003.03801.x RNA interference may be more potent than antisense RNA in human cancer cell lines
Nature Bass 411 428 2001 10.1038/35078175 RNA interference. The short answer
Oligonucleotides Coma 14 100 2004 10.1089/1545457041526290 Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis
Antisense Nucleic Acid Drug Dev. Miyagishi 13 1 2003 10.1089/108729003764097296 Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells
Blood Scherr 101 1566 2003 10.1182/blood-2002-06-1685 Specific inhibition of bcr-abl gene expression by small interfering RNA
Cancer Cells Brummelkamp 2 243 2002 10.1016/S1535-6108(02)00122-8 Stable suppression of tumorigenicity by virus-mediated RNA interference
Proc. Natl. Acad. Sci. U. S. A. Martinez 99 14,849 2002 10.1073/pnas.222406899 Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways
Mol. Ther. Yoshinouchi 8 762 2003 10.1016/j.ymthe.2003.08.004 In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA
Int. J. Cancer Choudhury 108 71 2004 10.1002/ijc.11497 Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines
J. Biol. Chem. Yang 279 4339 2004 10.1074/jbc.M311153200 Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression
Surgery Farrow 134 197 2003 10.1067/msy.2003.220 Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A
Gene Ther. Yague 11 1170 2004 10.1038/sj.gt.3302269 Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1
Mol. Cancer Ther. Kosciolek 2 209 2003 Inhibition of telomerase activity in human cancer cells by RNA interference
Cancer Gene Ther. Cioca 10 125 2003 10.1038/sj.cgt.7700544 RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines
Nucleic Acids Res. Kawasaki 31 700 2003 10.1093/nar/gkg158 Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells
Cancer Res. Li 63 3593 2003 Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma
Clin. Cancer Res. Verma 9 1291 2003 Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells
Cancer Res. Aharinejad 64 5378 2004 10.1158/0008-5472.CAN-04-0961 Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
Mol. Ther. Uchida 10 162 2004 10.1016/j.ymthe.2004.05.006 Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo
Horm. Metab. Res. Salisbury 35 843 2003 10.1055/s-2004-814158 Development of molecular agents for IGF receptor targeting
Surgery Duxbury 135 555 2004 10.1016/j.surg.2003.10.017 Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells
Ann. Surg. Duxbury 240 667 2004 10.1097/01.sla.0000140755.97224.9a Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer
Cancer Res. Filleur 63 3919 2003 SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth
Cancer Res. Takei 64 3365 2004 10.1158/0008-5472.CAN-03-2682 A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics
Oncogene Lakka 23 4681 2004 10.1038/sj.onc.1207616 Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis
Cancer Res. Singh 68 7975 2008 10.1158/0008-5472.CAN-08-1401 RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
Int. J. Cancer Nakahira 120 1355 2007 10.1002/ijc.22390 Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Nature Fire 391 806 1998 10.1038/35888 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Proc. Natl. Acad. Sci. U. S. A. Yu 99 6047 2002 10.1073/pnas.092143499 RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
Nat. Biotechnol. Miyagishi 20 497 2002 10.1038/nbt0502-497 U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells
Nucleic Acids Res. Jarve 35 e124 2007 10.1093/nar/gkm694 Surveillance of siRNA integrity by FRET imaging
Proc. Natl. Acad. Sci. U. S. A. Leonetti 88 2702 1991 10.1073/pnas.88.7.2702 Intracellular distribution of microinjected antisense oligonucleotides
Nat. Struct. Mol. Biol. Robb 12 133 2005 10.1038/nsmb886 Specific and potent RNAi in the nucleus of human cells
Proc. Natl. Acad. Sci. U. S. A. Berezhna 103 7682 2006 10.1073/pnas.0600148103 siRNA in human cells selectively localizes to target RNA sites
Nat. Struct. Mol. Biol. Janowski 13 787 2006 10.1038/nsmb1140 Involvement of AGO1 and AGO2 in mammalian transcriptional silencing
Nat. Struct. Mol. Biol. Kim 13 793 2006 10.1038/nsmb1142 Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells
RNA Rudel 14 1244 2008 10.1261/rna.973808 A multifunctional human Argonaute2-specific monoclonal antibody
Nucleic Acids Res. Ohrt 36 6439 2008 10.1093/nar/gkn693 Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells
Cell Weinmann 136 496 2009 10.1016/j.cell.2008.12.023 Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs
Science Guang 321 537 2008 10.1126/science.1157647 An Argonaute transports siRNAs from the cytoplasm to the nucleus
Oligonucleotides Grunweller 13 345 2003 10.1089/154545703322617023 Cellular uptake and localization of a Cy3-labeled siRNA specific for the serine/threonine kinase Pim-1
Nucleic Acids Res. Ohrt 34 1369 2006 10.1093/nar/gkl001 In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by exportin 5
Chem. Biol. Chiu 11 1165 2004 10.1016/j.chembiol.2004.06.006 Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
PLoS. Biol. Forstemann 3 e236 2005 10.1371/journal.pbio.0030236 Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein
Genes Dev. Jiang 19 1674 2005 10.1101/gad.1334005 Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila
PLoS. Biol. Saito 3 e235 2005 10.1371/journal.pbio.0030235 Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells
RNA Liu 13 2324 2007 10.1261/rna.723707 Dicer-1, but not Loquacious, is critical for assembly of miRNA-induced silencing complexes
Proc. Natl. Acad. Sci. U. S. A. Murchison 102 12,135 2005 10.1073/pnas.0505479102 Characterization of Dicer-deficient murine embryonic stem cells
Nature Bernstein 409 363 2001 10.1038/35053110 Role for a bidentate ribonuclease in the initiation step of RNA interference
EMBO J. Provost 21 5864 2002 10.1093/emboj/cdf578 Ribonuclease activity and RNA binding of recombinant human Dicer
Nat. Rev., Genet. Hammond 2 110 2001 10.1038/35052556 Post-transcriptional gene silencing by double-stranded RNA
Nat. Struct. Mol. Biol. Carmell 11 214 2004 10.1038/nsmb729 RNase III enzymes and the initiation of gene silencing
Science Macrae 311 195 2006 10.1126/science.1121638 Structural basis for double-stranded RNA processing by Dicer
J. Biol. Chem. Kok 282 17,649 2007 10.1074/jbc.M611768200 Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA
Mol. Cell Robb 26 523 2007 10.1016/j.molcel.2007.04.016 RNA helicase A interacts with RISC in human cells and functions in RISC loading
Cell Matranga 123 607 2005 10.1016/j.cell.2005.08.044 Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes
Cell Rand 123 621 2005 10.1016/j.cell.2005.10.020 Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation
EMBO Rep. Leuschner 7 314 2006 10.1038/sj.embor.7400637 Cleavage of the siRNA passenger strand during RISC assembly in human cells
Cell Preall 123 543 2005 10.1016/j.cell.2005.11.006 RNAi: RISC gets loaded
Nat. Struct. Mol. Biol. Haley 11 599 2004 10.1038/nsmb780 Kinetic analysis of the RNAi enzyme complex
Cell Gregory 123 631 2005 10.1016/j.cell.2005.10.022 Human RISC couples microRNA biogenesis and posttranscriptional gene silencing
Genes Dev. Maniataki 19 2979 2005 10.1101/gad.1384005 A human, ATP-independent, RISC assembly machine fueled by pre-miRNA
J. Cell. Biochem. Collins 99 1251 2006 10.1002/jcb.21069 Structural and biochemical advances in mammalian RNAi
RNA Boudreau 14 1834 2008 10.1261/rna.1062908 Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs
Nat. Genet. Cullen 37 1163 2005 10.1038/ng1105-1163 RNAi the natural way
EMBO J. Zeng 24 138 2005 10.1038/sj.emboj.7600491 Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha
Nat. Genet. Silva 37 1281 2005 10.1038/ng1650 Second-generation shRNA libraries covering the mouse and human genomes
Nature Lee 425 415 2003 10.1038/nature01957 The nuclear RNase III Drosha initiates microRNA processing
EMBO J. Zhang 21 5875 2002 10.1093/emboj/cdf582 Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP
EMBO J. Lee 21 4663 2002 10.1093/emboj/cdf476 MicroRNA maturation: stepwise processing and subcellular localization
Mol. Cell Cullen 16 861 2004 10.1016/j.molcel.2004.12.002 Transcription and processing of human microRNA precursors
Genes Dev. Yi 17 3011 2003 10.1101/gad.1158803 Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Science Lund 303 95 2004 10.1126/science.1090599 Nuclear export of microRNA precursors
Cell Lee 117 69 2004 10.1016/S0092-8674(04)00261-2 Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways
RNA Landthaler 14 2580 2008 10.1261/rna.1351608 Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs
Science Hammond 293 1146 2001 10.1126/science.1064023 Argonaute2, a link between genetic and biochemical analyses of RNAi
Science Sontheimer 305 1409 2004 10.1126/science.1103076 Molecular biology. Argonaute journeys into the heart of RISC
Science Hutvagner 297 2056 2002 10.1126/science.1073827 A microRNA in a multiple-turnover RNAi enzyme complex
Science Yekta 304 594 2004 10.1126/science.1097434 MicroRNA-directed cleavage of HOXB8 mRNA
Proc. Natl. Acad. Sci. U. S. A. Humphreys 102 16,961 2005 10.1073/pnas.0506482102 MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function
Science Pillai 309 1573 2005 10.1126/science.1115079 Inhibition of translational initiation by Let-7 MicroRNA in human cells
Nature Thermann 447 875 2007 10.1038/nature05878 Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation
Genes Dev. Valencia-Sanchez 20 515 2006 10.1101/gad.1399806 Control of translation and mRNA degradation by miRNAs and siRNAs
Mol. Cell Parker 25 635 2007 10.1016/j.molcel.2007.02.011 P bodies and the control of mRNA translation and degradation
Genes Dev. Okamura 18 1655 2004 10.1101/gad.1210204 Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways
Genes Dev. Miyoshi 19 2837 2005 10.1101/gad.1370605 Slicer function of Drosophila Argonautes and its involvement in RISC formation
Cell Tomari 130 299 2007 10.1016/j.cell.2007.05.057 Sorting of Drosophila small silencing RNAs
Cell Forstemann 130 287 2007 10.1016/j.cell.2007.05.056 Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by dicer-1
Nat. Struct. Mol. Biol. Steiner 14 927 2007 10.1038/nsmb1308 Structural features of small RNA precursors determine Argonaute loading in Caenorhabditis elegans
Proc. Natl. Acad. Sci. U. S. A. Azuma-Mukai 105 7964 2008 10.1073/pnas.0800334105 Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing
PLoS ONE Hendrickson 3 e2126 2008 10.1371/journal.pone.0002126 Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance
Nature Tay 455 1124 2008 10.1038/nature07299 MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Nucleic Acids Res. Sano 36 5812 2008 10.1093/nar/gkn584 Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection
Nat. Biotechnol. Kim 23 222 2005 10.1038/nbt1051 Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
J. Pharm. Sci. McAnuff 96 2922 2007 10.1002/jps.20968 Potency of siRNA versus shRNA mediated knockdown in vivo
Nat. Biotechnol. Siolas 23 227 2005 10.1038/nbt1052 Synthetic shRNAs as potent RNAi triggers
Oligonucleotides Vlassov 17 223 2007 10.1089/oli.2006.0069 shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA
Proc. Natl. Acad. Sci. U. S. A. Gossen 89 5547 1992 10.1073/pnas.89.12.5547 Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
Proc. Natl. Acad. Sci. U. S. A. Gupta 101 1927 2004 10.1073/pnas.0306111101 Inducible, reversible, and stable RNA interference in mammalian cells
Nat. Genet. Dickins 37 1289 2005 10.1038/ng1651 Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Curr. Opin. Mol. Ther. Tong 7 114 2005 Small interfering RNA for experimental cancer therapy
Curr. Pharm. Des. Aigner 14 3603 2008 10.2174/138161208786898815 Cellular delivery in vivo of siRNA-based therapeutics
Curr. Gene Ther. Tong 9 1 45 2009 10.2174/156652309787354630 Systemic therapeutic gene delivery for cancer: crafting Paris' arrow
Expert Rev. Anticancer Ther. Vorhies 7 373 2007 10.1586/14737140.7.3.373 Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies
Nature McCaffrey 418 38 2002 10.1038/418038a RNA interference in adult mice
N. Engl. J. Med. Merritt 359 2641 2008 10.1056/NEJMoa0803785 Dicer, Drosha, and outcomes in patients with ovarian cancer
Nature Lu 435 834 2005 10.1038/nature03702 MicroRNA expression profiles classify human cancers
Science Sandberg 320 1643 2008 10.1126/science.1155390 Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites
Am. J. Pathol. Chiosea 169 1812 2006 10.2353/ajpath.2006.060480 Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma
Clin. Cancer Res. Sugito 12 7322 2006 10.1158/1078-0432.CCR-06-0515 RNASEN regulates cell proliferation and affects survival in esophageal cancer patients
Carcinogenesis Tokumaru 29 2073 2008 10.1093/carcin/bgn187 Let-7 regulates Dicer expression and constitutes a negative feedback loop
Proc. Natl. Acad. Sci. U. S. A. Forman 105 14,879 2008 10.1073/pnas.0803230105 A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence
vol. 6 2008 Breakdown of RNAi-Based Drugs in the Clinic
Clin. Cancer Res. Heidel 13 2207 2007 10.1158/1078-0432.CCR-06-2218 Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo
Cancer Biol. Ther. Zukiel 5 1002 2006 10.4161/cbt.5.8.2886 Suppression of human brain tumor with interference RNA specific for tenascin-C
Proc. Natl. Acad. Sci. U. S. A. Heidel 104 5715 2007 10.1073/pnas.0701458104 Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
Nature Check 420 116 2002 10.1038/420116a A tragic setback
Curr. Opin. Mol. Ther. Nguyen 10 158 2008 RNAi therapeutics: an update on delivery
J. Control. Release Luten 126 97 2008 10.1016/j.jconrel.2007.10.028 Biodegradable polymers as non-viral carriers for plasmid DNA delivery
J. Control. Release Zhang 123 1 2007 10.1016/j.jconrel.2007.07.016 Cationic lipids and polymers mediated vectors for delivery of siRNA
Curr. Opin. Mol. Ther. Aigner 9 345 2007 Nonviral in vivo delivery of therapeutic small interfering RNAs
Expert Opin. Drug Deliv. Hughes 2 145 2005 10.1517/17425247.2.1.145 Targeted polymers for gene delivery
J. Biomed. Mater. Res. Godbey 51 321 2000 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.0.CO;2-R Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery
Proc. Natl. Acad. Sci. U. S. A. Thomas 99 14,640 2002 10.1073/pnas.192581499 Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells
J. Control. Release Kim 134 2 132 2009 10.1016/j.jconrel.2008.10.020 Polymersome delivery of siRNA and antisense oligonucleotides
Expert Opin. Drug Deliv. Heidel 3 641 2006 10.1517/17425247.3.5.641 Linear cyclodextrin-containing polymers and their use as delivery agents
J. Nanosci. Nanotechnol. Moreira 8 2187 2008 10.1166/jnn.2008.319 Non-viral lipid-based nanoparticles for targeted cancer systemic gene silencing
Nature Blow 450 1117 2007 10.1038/4501117a Small RNAs: delivering the future
Nature Zimmermann 441 111 2006 10.1038/nature04688 RNAi-mediated gene silencing in non-human primates
Gene Ther. Santel 13 1360 2006 10.1038/sj.gt.3302778 RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy
Gene Ther. Santel 13 1222 2006 10.1038/sj.gt.3302777 A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Microvasc. Res. Aleku 76 31 2008 10.1016/j.mvr.2008.02.004 Intracellular localization of lipoplexed siRNA in vascular endothelial cells of different mouse tissues
Cancer Res. Aleku 68 9788 2008 10.1158/0008-5472.CAN-08-2428 Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression
Methods Mol. Biol. Vorhies 480 11 2009 10.1007/978-1-59745-429-2_2 Synthetic vs. natural/biodegradable polymers for delivery of shRNA-based cancer therapies
Cell Kumar 134 577 2008 10.1016/j.cell.2008.06.034 T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
10.1021/mp800134q K. Gao, L. Huang, Nonviral methods for siRNA Delivery, Mol. Pharmacol. 2008 Dec 30.
Nat. Biotechnol. Akinc 26 561 2008 10.1038/nbt1402 A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Connect. Tissue Res. Ghatak 49 265 2008 10.1080/03008200802147845 Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer
Nature Kumar 448 39 2007 10.1038/nature05901 Transvascular delivery of small interfering RNA to the central nervous system
Hum. Gene Ther. Judge 19 111 2008 10.1089/hum.2007.179 Overcoming the innate immune response to small interfering RNA
J. Control. Release Lv 114 100 2006 10.1016/j.jconrel.2006.04.014 Toxicity of cationic lipids and cationic polymers in gene delivery
Adv. Drug Deliv. Rev. Park 58 467 2006 10.1016/j.addr.2006.03.007 Current status of polymeric gene delivery systems
Proc. Natl. Acad. Sci. U. S. A. Breunig 104 14,454 2007 10.1073/pnas.0703882104 Breaking up the correlation between efficacy and toxicity for nonviral gene delivery
Nat. Biotechnol. Jackson 21 635 2003 10.1038/nbt831 Expression profiling reveals off-target gene regulation by RNAi
RNA Jackson 12 1179 2006 10.1261/rna.25706 Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Nucleic Acids Res. Lin 33 4527 2005 10.1093/nar/gki762 siRNA-mediated off-target gene silencing triggered by a 7 nt complementation
RNA Jackson 12 1197 2006 10.1261/rna.30706 Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Nat. Methods Birmingham 3 199 2006 10.1038/nmeth854 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Methods Mol. Biol. Anderson 442 45 2008 10.1007/978-1-59745-191-8_4 Identifying siRNA-induced off-targets by microarray analysis
Nat. Methods van Dongen 5 1023 2008 10.1038/nmeth.1267 Detecting microRNA binding and siRNA off-target effects from expression data
Nucleic Acids Res. Qiu 33 1834 2005 10.1093/nar/gki324 A computational study of off-target effects of RNA interference
Nucleic Acids Res. Park 36 W97 2008 10.1093/nar/gkn280 AsiDesigner: exon-based siRNA design server considering alternative splicing
Bioinformatics Yamada 21 1316 2005 10.1093/bioinformatics/bti155 Accelerated off-target search algorithm for siRNA
Nucleic Acids Res. Naito 33 W589 2005 10.1093/nar/gki419 dsCheck: highly sensitive off-target search software for double-stranded RNA-mediated RNA interference
Nucleic Acids Res. Du 33 1671 2005 10.1093/nar/gki312 A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
PLoS Genet. Schwarz 2 e140 2006 10.1371/journal.pgen.0020140 Designing siRNA that distinguish between genes that differ by a single nucleotide
Nucleic Acids Res. Dahlgren 36 e53 2008 10.1093/nar/gkn190 Analysis of siRNA specificity on targets with double-nucleotide mismatches
Drug Discov. Today Watts 13 842 2008 10.1016/j.drudis.2008.05.007 Chemically modified siRNA: tools and applications
ACS Chem. Biol. Snove 1 274 2006 10.1021/cb6002256 Chemical modifications rescue off-target effects of RNAi
Oligonucleotides Behlke 18 305 2008 10.1089/oli.2008.0164 Chemical modification of siRNAs for in vivo use
Nucleic Acids Res. Bramsen 35 5886 2007 10.1093/nar/gkm548 Improved silencing properties using small internally segmented interfering RNAs
RNA Chen 14 263 2008 10.1261/rna.789808 Strand-specific 5′-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity
Nucleic Acids Res. Ui-Tei 36 2136 2008 10.1093/nar/gkn042 Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect
10.1038/cgt.2009.53 D. Rao, N. Senzer, M.A. Cleary, J. Nemunaitis, Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development. Cancer Gene Therapy (2009).
Nat. Chem. Biol. Bumcrot 2 711 2006 10.1038/nchembio839 RNAi therapeutics: a potential new class of pharmaceutical drugs
Nat. Genet. Bridge 34 263 2003 10.1038/ng1173 Induction of an interferon response by RNAi vectors in mammalian cells
Nat. Cell Biol. Sledz 5 834 2003 10.1038/ncb1038 Activation of the interferon system by short-interfering RNAs
J. Immunol. Kariko 172 6545 2004 10.4049/jimmunol.172.11.6545 Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3
Nat. Med. Hornung 11 263 2005 10.1038/nm1191 Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7
Nat. Biotechnol. Judge 23 457 2005 10.1038/nbt1081 Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Science Diebold 303 1529 2004 10.1126/science.1093616 Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Science Heil 303 1526 2004 10.1126/science.1093620 Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Nat. Rev., Drug Discov. Karin 3 17 2004 10.1038/nrd1279 The IKK NF-kappa B system: a treasure trove for drug development
Nat. Biotechnol. Marques 24 559 2006 10.1038/nbt1205 A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells
Adv. Drug Deliv. Rev. Sioud 59 153 2007 10.1016/j.addr.2007.03.006 RNA interference and innate immunity
Nature Kleinman 452 591 2008 10.1038/nature06765 Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Hum. Gene Ther. Robbins 19 10 991 2008 10.1089/hum.2008.131 Misinterpreting the therapeutic effects of siRNA caused by immune stimulation
Proc. Natl. Acad. Sci. U. S. A. Bauer 98 9237 2001 10.1073/pnas.161293498 Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Nature Hemmi 408 740 2000 10.1038/35047123 A toll-like receptor recognizes bacterial DNA
Pharm. Res. de Wolf 25 1654 2008 10.1007/s11095-008-9558-7 Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes
Nat. Biotechnol. Robbins 24 566 2006 10.1038/nbt1206 Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro
J. Mol. Biol. Sioud 348 1079 2005 10.1016/j.jmb.2005.03.013 Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
Mol. Biosyst. Akashi 1 382 2005 10.1039/b510159j Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA
Gene Ther. Watanabe 13 883 2006 10.1038/sj.gt.3302734 Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype
Gene Ther. Bauer 16 142 2009 10.1038/gt.2008.123 Prevention of interferon-stimulated gene expression using microRNA-designed hairpins
Eur. J. Immunol. Sioud 36 1222 2006 10.1002/eji.200535708 Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses
RNA Layzer 10 766 2004 10.1261/rna.5239604 In vivo activity of nuclease-resistant siRNAs
Immunity Kariko 23 165 2005 10.1016/j.immuni.2005.06.008 Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA
Nature Grimm 441 537 2006 10.1038/nature04791 Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
J. Clin. Invest. Grimm 117 3633 2007 10.1172/JCI34129 Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
Nature John 449 745 2007 10.1038/nature06179 Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway
RNA Yi 11 220 2005 10.1261/rna.7233305 Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs
Mol. Ther. Giering 16 1630 2008 10.1038/mt.2008.144 Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.